← SynDRA
CGM-097
SynDRA canonical compound SYN0038335 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MDM2 | TP53 |
| Mechanism of action | MDM inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CGM 097
- CGM097
- NVP-CGM-097
- NVP CGM097
- 4UF6MSL0ZH
- NVP-CGM097 (CGM-097)
- (1S)-1-(4-chlorophenyl)-6-methoxy-2-[4-[methyl-[[4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl]methyl]amino]phenyl]-7-propan-2-yloxy-1,4-dihydroisoquinolin-3-one
- (S)-1-(4-Chlorophenyl)-7-Isopropoxy-6-Methoxy-2-(4-(Methyl(((1r,4s)-4-(4-Methyl-3-Oxopiperazin-1-Yl)cyclohexyl)methyl)amino)phenyl)-1,2-Dihydroisoquinolin-3(4h)-One
- (S)-1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-[methyl[4-(4-methyl-3-oxopiperazin-1-yl)-trans-cyclohexylmethyl]amino]phenyl)-1,4-dihydro-2H-isoquinolin-3-one
- (1S)-1-(4-chlorophenyl)-1,4-dihydro-6-methoxy-7-(1-methylethoxy)-2-[4-[methyl[[trans-4-(4-methyl-3-oxo-1-piperazinyl)cyclohexyl]methyl]amino]phenyl]-3(2H)-isoquinolinone
- (1S)-1-(4-CHLOROPHENYL)-1,4-DIHYDRO-6-METHOXY-7-(1-METHYLETHOXY)-2-(4-(METHYL((TRANS-4-(4-METHYL-3-OXO-1-PIPERAZINYL)CYCLOHEXYL)METHYL)AMINO)PHENYL)-3(2H)-ISOQUINOLINONE
- CGM097 dihydrochloride
- UNII-4UF6MSL0ZH
- NVP-CGM097 dihydrochloride
- CGM097CGM097
- SCHEMBL2391192
- SCHEMBL2391196
- CGM 097 [WHO-DD]
- CHEMBL3601398
- SCHEMBL18458199
- BDBM162123
- BCP18308
- EX-A1059
- MFCD28144684
- NSC783015
- s7875
- AKOS030526402
- ZINC253387855
- CCG-270337
- CS-3138
- NSC-783015
- CGM097 stereoisomer;(R)-Nvp-Cgm097
- NCGC00390552-01
- AC-32967
- AS-75288
- HY-15954
- J3.509.326E
- A16326
- US9051279, 106
Look up CGM-097 in the interactive SynDRA portal →